Ipsen

From molecule to medicine: the process behind patient-ready treatments

“We need to make sure that it’s scalable, safe, and reproducible—so that every patient gets the same medicine every time.”   As The post From molecule to medicine: the process behind patient-ready treatments appeared first on Global .

Excellent growth and progress in H1 2026

What a start to 2026! We announced excellent financial results today. Total sales grew by 23.5% at constant exchange rates, The post Excellent growth and progress in H1 2026 appeared first on Global .

Finding Light Again: Rajminder’s Malhi Journey

For Rajminder, the past five years have been marked by challenges that affected every aspect of her life. As a mother and The post Finding Light Again: Rajminder’s Malhi Journey appeared first on Global .

When bile acids tell a bigger story: how cholestatic biology is reshaping rare liver disease research

. Jennifer Schranz, Senior Vice President, Head of Rare Diseases   The human cost of a system out of balance   Over The post When bile acids tell a bigger story: how cholestatic biology is reshaping rare liver disease research appeared first on Global .

Testing the hypothesis: a focused pilot for AI in healthcare

Every scientific breakthrough begins with a question: can this medicine extend life, restore balance, or meaningfully change what is possible The post Testing the hypothesis: a focused pilot for AI in healthcare appeared first on Global .

Always one step ahead: Anne Petit on making medicines happen

Anne Petit does not wait for instructions. She knows that in pharmaceutical development, her team often moves first. “We always The post Always one step ahead: Anne Petit on making medicines happen appeared first on Global .